Farxiga 50 mg
Rs 266 15 % Off
Package size
Estimate Delivery by:
Delivering to
Easy 7 days return available
Farxiga 50 mg
Farxiga can be used for lowering the risk of sustained estimated glomerular filtration rate (eGFR) decline, end-stage kidney disease (ESKD), cardiovascular (CV) death and hospitalisation for heart failure (hHF) in CKD patients.
An oral, once-daily sodium-glucose cotransporter 2 (SGLT2) inhibitor, Farxiga was granted priority review in the US for treating CKD patients in January this year.
Lorem Ipsum is simply dummy text of the printing and typesetting industry. Lorem Ipsum has been the industry's standard dummy text ever since the 1500s
Recent Posts
-
October 18, 2015
-
October 18, 2015
Products
-
-
100$